Compare PRTC & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRTC | CARE |
|---|---|---|
| Founded | 2015 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 386.7M | 456.8M |
| IPO Year | N/A | N/A |
| Metric | PRTC | CARE |
|---|---|---|
| Price | $16.75 | $19.05 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.1K | ★ 74.9K |
| Earning Date | 08-28-2025 | 01-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 118.48 |
| EPS | 0.20 | ★ 1.36 |
| Revenue | $6,391,000.00 | ★ $154,517,000.00 |
| Revenue This Year | N/A | $10.69 |
| Revenue Next Year | N/A | $14.79 |
| P/E Ratio | ★ $7.86 | $14.02 |
| Revenue Growth | ★ 1265.60 | 20.24 |
| 52 Week Low | $13.30 | $13.61 |
| 52 Week High | $23.35 | $20.53 |
| Indicator | PRTC | CARE |
|---|---|---|
| Relative Strength Index (RSI) | 49.77 | 68.28 |
| Support Level | $16.01 | $18.21 |
| Resistance Level | $18.05 | $19.15 |
| Average True Range (ATR) | 0.34 | 0.34 |
| MACD | 0.17 | 0.20 |
| Stochastic Oscillator | 49.02 | 91.98 |
PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.
Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.